About Altis Labs
Altis Labs is a company based in Toronto (Canada) founded in 2018 by Felix Baldauf-Lenschen. Altis Labs has raised $6 million across 1 funding round from investors including Debiopharm, Richard Gliklich and Doug Foster. The company has 16 employees as of December 31, 2024. Altis Labs offers products and services including IPRO. Altis Labs operates in a competitive market with competitors including Neko Health, Medical IP, Foqus, Perfusion Tech and Tenyks, among others.
- Headquarter Toronto, Canada
- Employees 16 as on 31 Dec, 2024
- Founders Felix Baldauf-Lenschen
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Altis Labs, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$6 M (USD)
in 1 rounds
-
Latest Funding Round
$6 M (USD), Seed
Jun 21, 2023
-
Investors
Debiopharm
& 2 more
-
Employee Count
16
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Altis Labs
Altis Labs offers a comprehensive portfolio of products and services, including IPRO.
Predicts patient outcomes from CT scans for clinical research
People of Altis Labs
Unlock access to complete
Funding Insights of Altis Labs
Altis Labs has successfully raised a total of $6M through 1 strategic funding round. The most recent funding activity was a Seed round of $6 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Altis Labs
Altis Labs has secured backing from 3 investors, including institutional and angel investors. Prominent investors backing the company include Debiopharm, Richard Gliklich and Doug Foster.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biopharmaceutical company focused on oncology, infectious diseases, and orphan drugs
|
Locked | Locked | Locked | |
|
RG
Richard Gliklich |
Angel investor, CEO of Element Biosciences, focused on biotech innovation
|
Locked | Locked | Locked |
|
DF
Doug Foster |
Angel investor focusing on Indian startups, experienced in tech and innovation.
|
Locked | Locked | Locked |
Investor details for Altis Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Altis Labs
Investment portfolio details for Altis Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Altis Labs
Detailed financials for Altis Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Altis Labs Comparisons
Peer comparison for Altis Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Altis Labs
Altis Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Neko Health, Medical IP, Foqus, Perfusion Tech and Tenyks, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Platform offering solutions for preventive health scans
|
|
| Locked | Locked | Locked |
Medical imaging analysis platform is developed for healthcare applications.
|
|
| Locked | Locked | Locked |
Digital AI-based medical imaging tool for providers
|
|
| Locked | Locked | Locked |
Digital image analysis software is developed for medical providers.
|
|
| Locked | Locked | Locked |
AI-based tools for medical imaging and diagnostics are developed.
|
Detailed competitors of Altis Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Altis Labs
Complete news archive for Altis Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altis Labs
Altis Labs was founded in 2018 and raised its 1st funding round 5 years after it was founded.
Altis Labs is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Felix Baldauf-Lenschen is the current CEO of Altis Labs. They have also founded this company.
Altis Labs is a funded company, having raised a total of $6M across 1 funding round to date.
As of Dec 31, 2024, the latest employee count at Altis Labs is 16.
Altis Labs was founded in 2018 in Toronto, Canada, within the health technology sector. An online platform is operated to deliver insights from clinical imaging data using deep learning. Computed tomography, magnetic resonance imaging, and positron emission tomography scans are examined alongside patient history, records, demographics, and lab results. Treatment pathways and outcomes are predicted through this analysis.
Altis Labs's top competitors include Neko Health, Perfusion Tech and Medical IP.
Altis Labs offers IPRO.
Altis Labs has 3 investors. Key investors include Debiopharm, Richard Gliklich, and Doug Foster.